Citigroup raises AstraZeneca price target to 18,600p from 17,800p
Summary
Citigroup has raised its price target for AstraZeneca from 17,800p to 18,600p. This adjustment reflects the typical practice among major banks to revise price targets for pharmaceutical stocks based on updates in their development pipelines and strategic initiatives. AstraZeneca has recently been active in forming equity investments and clinical collaborations aimed at enhancing its cancer drug development efforts.
Tokens
$AZN
Analysis
Citigroup: Citigroup is a leading global financial services company providing banking, investment banking, and wealth management solutions. In the context of this news, it has issued an updated analyst report raising its price target on AstraZeneca shares. AstraZeneca: AstraZeneca is a major pharmaceutical company focused on developing treatments in oncology, respiratory, and other therapeutic areas. The firm is the subject of this analyst update from Citigroup, which reflects ongoing market interest in its business performance. Analyst Coverage: Major banks frequently adjust price targets on pharmaceutical stocks in response to pipeline updates and strategic moves. Pharma Partnerships: AstraZeneca has pursued recent equity investments and clinical collaborations to advance cancer drug development.
Categories
macro
Related sources
- https://www.ad-hoc-news.de/boerse/news/corporate-news/astrazeneca-investiert-2-milliarden-dollar-und-astrazeneca-aktie-kostet-140-38-euro/70230946
- https://www.ad-hoc-news.de/boerse/news/corporate-news/astrazeneca-expands-cancer-trials-as-analysts-rate-astrazeneca-stock-moderate-buy/70231641
- https://www.gurufocus.com/stock/C/article
- https://www.vcpost.com/tags/citigroup
- https://www.tikr.com/blog/citigroup-reports-q3-earnings-on-october-13-after-a-yield-driven-bank-selloff-heres-what-the-stock-needs-to-show
- https://www.tipranks.com/news/ratings/astrazeneca-buy-rating-reaffirmed-as-robust-pipeline-and-strategic-optionality-drive-price-target-raise-to-178-ratings-news
- https://www.lse.co.uk/news/aztrazeneca-opens-new-global-strategic-rd-centre-in-massachusetts-tt1rpgtenwyk5c9.html
- https://www.tipranks.com/news/ratings/astrazenecas-oncology-strategy-and-summit-deal-reinforce-growth-outlook-buy-rating-and-178-price-target-reiterated-ratings-news
- https://www.astrazeneca.com/media-centre.html
- https://www.ft.com/citigroup
- https://dhms8q85tpugt.cloudfront.net/stocks/xnys/c/quote
- https://www.cnbc.com/2026/10/05/astrazeneca-ceo-says-summit-drug-could-drive-future-cancer-combos.html
- https://www.tipranks.com/news/blurbs/citi-keeps-their-buy-rating-on-astrazeneca-azn-blurbs-news-2
- https://www.tipranks.com/news/the-fly/astrazeneca-price-target-lowered-to-17500-gbp-from-18000-gbp-at-citi-thefly-news
- https://www.marketbeat.com/all-access/ratings-screener/details/2436519/